NABAS

What NABAS does

NABAS (legal entity Nabas AS, Org nr 977 054 516) is a privately held Norwegian biotechnology company founded in 1997, headquartered at Moer Allé 33, Ås, Norway, with a headcount of 1-10 employees. The company manufactures polyclonal chicken IgY antibodies and affinity-purified antibody fractions for use in in vitro diagnostics (turbidimetric assays, lateral flow tests, ELISA kits) and life science research products. Its core technology exploits the genetic distance between chickens and mammals to generate strong immune responses against human antigens, with IgY extracted from egg yolk rather than blood — an animal-friendly method that, per the company, yields higher antibody concentrations at lower cost than mammalian antibody production. Quality is supported by ISO 9001:2015 certification maintained since 2016 and standard analytics including pH, protein concentration, conductivity, ELISA, Biacore, SDS-PAGE, and size exclusion chromatography.

The product portfolio is organized in two lines. The first is a standard catalog of approximately 35 affinity-purified polyclonal antibodies targeting human diagnostic biomarkers (CRP, PCT, PSA, Cystatin C, NGAL, Calprotectin, Fibrinogen, Hemoglobin, Transferrin, Apo TC, Holo TC, etc.), veterinary biomarkers (canine CRP, feline SAA, equine SAA, canine hemoglobin), and research targets (Protein A, GST, M13-K07, Hemocyanine), plus two bulk products (Chicken IgY A110-IgY and Ovalbumin B101-OVA). The second is a custom antibody development service where R&D personnel develop IgY antibodies to customer-specified antigens and quality specifications. Revenue mechanics combine a freemium sample program for catalog products with quote-based, multi-year contracts for custom work; no pricing is publicly disclosed. Distribution is direct via the company website (nabas.no) to IVD manufacturers in China, the USA, and Europe, with no third-party resellers mentioned. The company has no disclosed external funding, no M&A history, and no management team data in the public record.

Name

NABAS

Legal name

Nabas AS

Website

https://nabas.no

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

1–10 employees

Short description

NABAS is a privately held Norwegian biotech (founded 1997, 1-10 employees) that manufactures polyclonal chicken IgY antibodies and affinity-purified fractions for IVD manufacturers and life science researchers across China, the USA, and Europe.

Ownership category

akta.pro rank

Product category

Diagnostic Antibodies

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro industry

PRIMARYHLAMAEAK

Biologics & Immunotherapies (Non-vaccine)

Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

Keywords

• Chicken IgY antibodies
• Polyclonal antibody production
• In vitro diagnostics
• Immunodiagnostic reagents
• Affinity purified antibodies

Headquarters

HQ city

Ski

HQ country

Norway

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Standard Antibody Products: Sale of pre-made polyclonal chicken IgY antibodies and antigen-affinity purified antibodies from inventory. Products include various anti-human, anti-animal antibodies for diagnostics and research applications.
2. Custom Antibody Development: R&D services to develop specific IgY antibodies customized to customer applications, specifications, and quality requirements for their diagnostic products.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Core offering

NABAS manufactures polyclonal chicken IgY antibodies for use in in vitro diagnostics and life science products. The portfolio includes two core catalog products (Chicken IgY and Ovalbumin), over 35 antigen-specific affinity-purified polyclonal antibodies targeting human, veterinary, and research biomarkers, plus a customized antibody development service where R&D personnel develop IgY antibodies tailored to customer-specified antigens and quality requirements.

Product overview

NABAS is a Norwegian biotechnology company that manufactures polyclonal chicken IgY antibodies for in vitro diagnostics and life science products. Their product portfolio consists of two core offerings: (1) standard catalog products including Chicken IgY (A110-IgY), Ovalbumin (B101-OVA), and over 35 affinity-purified antigen-specific antibodies targeting human biomarkers (CRP, PCT, Cystatin C, PSA, NGAL, Ferritin, Hemoglobin, Transferrin, Apo TC, Holo TC, and others), veterinary biomarkers (Canine CRP, Feline SAA, Equine SAA), and research targets (GST, Protein A, M13-K07, Hemocyanine); and (2) Customized Antibodies service where R&D personnel assist in developing specific IgY antibodies tailored to customer applications, specifications, and quality requirements. Products are delivered as either complete IgY (18-22 mg/mL) or antigen-affinity purified fractions (1-3 mg/mL for most, 2-5 mg/mL for specialized products). NABAS chicken antibodies are used in commercial IVD products including turbidimetric assays, lateral flow tests, and ELISA kits.

Differentiator

Problem solved

Functional benefit

Products and services

• Chicken IgY (A110-IgY) Purified immunoglobulin fraction isolated from egg yolk of hyperimmune chicken eggs, supplied as a 0.2 µm sterile filtered solution in PBS pH 7.2 with concentration of 18-22 mg/mL. Used as a core reagent for IVD manufacturers and life science researchers.
• Ovalbumin (B101-OVA) Albumin purified from chicken egg white sourced from Moer Farm in Ås, Norway. Supplied in 0.010 M Borate, 0.015 M NaCl, pH 9.2-9.3 with concentration of 30-70 mg/mL, stored at -20°C. Used as a life science research reagent.
• Antigen-Specific Affinity-Purified Polyclonal IgY Antibody Catalog Catalog of over 35 antigen-affinity purified polyclonal chicken IgY antibodies targeting human diagnostic biomarkers (CRP, PCT, Cystatin C, PSA, NGAL, Ferritin, Hemoglobin, Transferrin, Apo TC, Holo TC, Calprotectin, Lactoferrin, Fibrinogen, HBP, NT-Pro-BNP, Lambda/Kappa Free Light Chain, Serum Albumin, Liver Ferritin, IgA, IgG Fc, Lipocalin-2/NGAL, SAH, GST), veterinary biomarkers (Canine CRP, Canine Hemoglobin, Feline SAA, Equine SAA), and research targets (Pseudomonas, Giardia, BSA, Protein A, M13-K07, Hemocyanine, Mouse IgG Fc). Used in turbidimetric assays, lateral flow tests, and ELISA kits by IVD manufacturers.
• Customized Antibody Development Service R&D service developing specific polyclonal chicken IgY antibodies tailored to customer-specified antigens, applications, specifications, and quality requirements. Products delivered as complete IgY and/or antigen affinity purified antibodies. Available to IVD manufacturers and life science companies globally.

Quantifiable outcome

• IgY concentration in egg yolk is ultimately higher than in blood, enabling efficient antibody harvesting

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Rockland Immunochemicals: Mid-sized US antibody manufacturer offering polyclonal and monoclonal antibodies plus custom services. Overlaps with NABAS in catalog antibodies for research and IVD-adjacent applications.
• Gallus Immunotech: Another niche IgY antibody producer serving research and diagnostic applications. Direct competitor to NABAS in the polyclonal chicken IgY space, with overlapping customer base in academic and industrial labs.
• Lampire Biological Laboratories: US-based contract manufacturer producing polyclonal antibodies in chickens, goats, rabbits, and other hosts. Comparable to NABAS on the IgY and custom polyclonal antibody side, with broader species coverage.
• Immunology Consultants Laboratory (ICL): Specialty polyclonal antibody manufacturer offering custom development and catalog products for diagnostics and research. Closely comparable in size, business model, and customer profile to NABAS.
• Cocalico Biologicals: Custom polyclonal antibody production service in rabbits, goats, and chickens. Directly competes with NABAS's custom antibody development offering for diagnostic and research customers.

Broad incumbents

• Bio-Rad Laboratories: Major life science research and clinical diagnostics company supplying antibodies, controls, and IVD components. Overlaps with NABAS as an antibody and IVD reagent supplier, though with vastly broader portfolio.
• Thermo Fisher Scientific: Largest life science tools and reagents supplier, including antibodies for IVD and research. Competes broadly with NABAS in antibody supply but as part of a vastly wider reagent portfolio.
• Abcam: Global antibody reagent catalog company (now part of Danaher) serving research and diagnostic customers. Comparable product overlap with NABAS's antibody catalog but at much larger scale and breadth.
• GenScript Biotech: Large publicly listed custom antibody and biologics provider with catalog and custom services. Adjacent to NABAS in custom antibody development and life science reagents, but at much greater scale and breadth.
• Merck KGaA (MilliporeSigma Life Science): Global life science supplier of antibodies, reagents, and diagnostic raw materials. Comparable in supplying antibody reagents to IVD manufacturers, but at much greater scale and with a broader portfolio.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/norwegian-antibodies-as

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NABAS